Ore. Says McKesson Artificially Inflated Drug Prices

Law360, New York (November 9, 2011, 4:56 PM EST) -- The state of Oregon on Monday sued McKesson Corp. in California federal court, claiming the drug distributor conspired to artificially inflate average wholesale drug prices, costing taxpayers millions in higher Medicaid reimbursements.

Oregon claims McKesson, the nation's largest pharmaceutical wholesaler, unlawfully inflated the published average wholesale prices for hundreds of brand name drugs — including Advair, Allegra, Celebrex, Flonase, Lipitor and Zyprexa.

The state says the price inflation scheme devised by McKesson and drug price publisher First DataBank Inc. caused pharmacies and other providers to submit...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

State of Oregon v. McKesson Corporation


Case Number

3:11-cv-05384

Court

California Northern

Nature of Suit

Racketeer/Corrupt Organization

Judge

Susan Illston

Date Filed

November 6, 2011

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.